Literature DB >> 20035375

Accelerated blood clearance was not induced for a gadolinium-containing PEG-poly(L-lysine)-based polymeric micelle in mice.

Huili Ma1, Kouichi Shiraishi, Takuya Minowa, Kumi Kawano, Masayuki Yokoyama, Yoshiyuki Hattori, Yoshie Maitani.   

Abstract

PURPOSE: Accelerated blood clearance (ABC) is induced by repeated injections of PEGylated liposomes. In this study, the ABC was investigated for a gadolinium-containing PEG-poly(L-lysine)-based polymeric micelle (Gd-micelle) and PEGylated liposome (Gd-liposome) in mice.
MATERIALS AND METHODS: Effects of the first injection of Gd-micelle on the tissue distribution of the second dose of Gd-micelle were studied. Additionally, effects of the first injection of Gd-micelle, Gd-liposome, empty liposome, polyethyleneglycol (PEG(500,000)), and PEG-lipid on the distribution of the second dose of the Gd-liposome were evaluated.
RESULTS: Results indicated that the tissue distribution of the second injection of the Gd-micelle at a dose of 33, 5, or 2 micromol Gd/kg was not affected by the first injection of the Gd-micelle at different doses and time intervals or of the empty PEGylated liposome 7 days before. ABC of Gd-liposome at a dose of 2.3 micromol Gd/kg (corresponding to 10 micromol lipids/kg) was observed when the empty PEGylated liposome or Gd-liposome, but not the Gd-micelle, PEG(500,000) or PEG-lipid, was pre-administered.
CONCLUSIONS: The hydrophobic core of the micelle or lipid bilayer of PEGylated liposome has a major effect on this phenomenon. These studies have significant implications for the evaluation of PEG-poly(L-lysine)-based micellar formulation of Gd-based contrast agents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20035375     DOI: 10.1007/s11095-009-0018-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  24 in total

1.  Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood.

Authors:  M Yokoyama; T Okano; Y Sakurai; H Ekimoto; C Shibazaki; K Kataoka
Journal:  Cancer Res       Date:  1991-06-15       Impact factor: 12.701

2.  Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes.

Authors:  XinYu Wang; Tatsuhiro Ishida; Hiroshi Kiwada
Journal:  J Control Release       Date:  2007-02-24       Impact factor: 9.776

3.  A polymeric micelle MRI contrast agent with changeable relaxivity.

Authors:  Emiko Nakamura; Kimiko Makino; Teruo Okano; Tatsuhiro Yamamoto; Masayuki Yokoyama
Journal:  J Control Release       Date:  2006-06-15       Impact factor: 9.776

4.  Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.

Authors:  E T Dams; P Laverman; W J Oyen; G Storm; G L Scherphof; J W van Der Meer; F H Corstens; O C Boerman
Journal:  J Pharmacol Exp Ther       Date:  2000-03       Impact factor: 4.030

5.  Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes.

Authors:  Adam Judge; Kevin McClintock; Janet R Phelps; Ian Maclachlan
Journal:  Mol Ther       Date:  2005-11-07       Impact factor: 11.454

6.  Influence of the physicochemical properties of liposomes on the accelerated blood clearance phenomenon in rats.

Authors:  Xin Yu Wang; Tatsuhiro Ishida; Masako Ichihara; Hiroshi Kiwada
Journal:  J Control Release       Date:  2005-05-05       Impact factor: 9.776

7.  Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection.

Authors:  P Laverman; M G Carstens; O C Boerman; E T Dams; W J Oyen; N van Rooijen; F H Corstens; G Storm
Journal:  J Pharmacol Exp Ther       Date:  2001-08       Impact factor: 4.030

Review 8.  Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging.

Authors:  Willem J M Mulder; Gustav J Strijkers; Geralda A F van Tilborg; Arjan W Griffioen; Klaas Nicolay
Journal:  NMR Biomed       Date:  2006-02       Impact factor: 4.044

9.  Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes.

Authors:  Tatsuhiro Ishida; Masako Ichihara; XinYu Wang; Kenji Yamamoto; Junji Kimura; Eiji Majima; Hiroshi Kiwada
Journal:  J Control Release       Date:  2006-03-03       Impact factor: 9.776

10.  Preparation and in vivo imaging of PEG-poly(L-lysine)-based polymeric micelle MRI contrast agents.

Authors:  Kouichi Shiraishi; Kumi Kawano; Takuya Minowa; Yoshie Maitani; Masayuki Yokoyama
Journal:  J Control Release       Date:  2009-01-23       Impact factor: 9.776

View more
  8 in total

Review 1.  Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.

Authors:  Nazila Kamaly; Zeyu Xiao; Pedro M Valencia; Aleksandar F Radovic-Moreno; Omid C Farokhzad
Journal:  Chem Soc Rev       Date:  2012-03-05       Impact factor: 54.564

2.  Factors influencing in vivo disposition of polymeric micelles on multiple administrations.

Authors:  Eri Hara; Motoki Ueda; Akira Makino; Isao Hara; Eiichi Ozeki; Shunsaku Kimura
Journal:  ACS Med Chem Lett       Date:  2014-06-18       Impact factor: 4.345

3.  Effects of stability of PEGylated micelles on the accelerated blood clearance phenomenon.

Authors:  Yuqing Su; Mengyang Liu; Yan Xiong; Junqiang Ding; Xinrong Liu; Yanzhi Song; Yihui Deng
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

4.  Accelerated blood clearance of PEGylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug.

Authors:  Roonak Saadati; Simin Dadashzadeh; Zahra Abbasian; Hoorieh Soleimanjahi
Journal:  Pharm Res       Date:  2012-11-27       Impact factor: 4.200

5.  Impact of large aggregated uricases and PEG diol on accelerated blood clearance of PEGylated canine uricase.

Authors:  Chun Zhang; Kai Fan; Xuefeng Ma; Dongzhi Wei
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

6.  Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats.

Authors:  Masako Ichihara; Taro Shimizu; Ami Imoto; Yuki Hashiguchi; Yumi Uehara; Tatsuhiro Ishida; Hiroshi Kiwada
Journal:  Pharmaceutics       Date:  2010-12-27       Impact factor: 6.321

Review 7.  Toxicity and immunogenicity concerns related to PEGylated-micelle carrier systems: a review.

Authors:  Kouichi Shiraishi; Masayuki Yokoyama
Journal:  Sci Technol Adv Mater       Date:  2019-04-15       Impact factor: 8.090

8.  Higher lung accumulation of intravenously injected organic nanotubes.

Authors:  Yoshie Maitani; Yuri Nakamura; Masao Kon; Emi Sanada; Kae Sumiyoshi; Natsuki Fujine; Masumi Asakawa; Masaki Kogiso; Toshimi Shimizu
Journal:  Int J Nanomedicine       Date:  2013-01-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.